5 Stocks Dragging In The Health Services Industry

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 24 points (-0.2%) at 15,303 as of Thursday, Sept. 12, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 960 issues advancing vs. 1,922 declining with 143 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.3%. On the negative front, top decliners within the industry include Intuitive Surgical ( ISRG), down 1.4%, DENTSPLY International ( XRAY), down 1.2%, Varian Medical Systems ( VAR), down 1.1%, Cooper Companies ( COO), down 1.1% and C.R. Bard ( BCR), down 0.8%.

TheStreet would like to highlight 5 stocks pushing the industry lower today:

5. CareFusion ( CFN) is one of the companies pushing the Health Services industry lower today. As of noon trading, CareFusion is down $0.36 (-1.0%) to $37.02 on light volume. Thus far, 623,119 shares of CareFusion exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $37.00-$37.39 after having opened the day at $37.38 as compared to the previous trading day's close of $37.39.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. CareFusion has a market cap of $8.0 billion and is part of the health care sector. Shares are up 29.9% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full CareFusion Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

4. As of noon trading, Catamaran ( CTRX) is down $0.55 (-1.0%) to $54.71 on light volume. Thus far, 162,044 shares of Catamaran exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $54.66-$55.41 after having opened the day at $55.07 as compared to the previous trading day's close of $55.26.

Catamaran Corporation provides pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefits management industry in North America. The company operates in two segments: PBM and HCIT. Catamaran has a market cap of $11.4 billion and is part of the health care sector. Shares are up 17.7% year to date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Catamaran a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Catamaran as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, compelling growth in net income and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Catamaran Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

3. As of noon trading, Stryker Corporation ( SYK) is down $0.42 (-0.6%) to $69.16 on light volume. Thus far, 398,950 shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.2 million shares. The stock has ranged in price between $69.12-$69.52 after having opened the day at $69.46 as compared to the previous trading day's close of $69.58.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. Stryker Corporation has a market cap of $26.3 billion and is part of the health care sector. Shares are up 26.9% year to date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Baxter International ( BAX) is down $0.74 (-1.0%) to $71.50 on average volume. Thus far, 1.0 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.7 million shares. The stock has ranged in price between $71.45-$72.30 after having opened the day at $72.24 as compared to the previous trading day's close of $72.24.

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.8 billion and is part of the health care sector. Shares are up 7.2% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Medtronic ( MDT) is down $0.29 (-0.5%) to $53.80 on light volume. Thus far, 1.4 million shares of Medtronic exchanged hands as compared to its average daily volume of 5.0 million shares. The stock has ranged in price between $53.78-$54.21 after having opened the day at $54.07 as compared to the previous trading day's close of $54.09.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $53.8 billion and is part of the health care sector. Shares are up 31.5% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, growth in earnings per share, increase in net income and reasonable valuation levels. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Medtronic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%